Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Frontiers in Immunology|June 15, 2026
MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infectionFranziska Rodner, Klaus Schughart, Stephan Ludwig, et al.
Journal of Leukocyte Biology|February 21, 2012
Apoptosis signaling in influenza virus propagation, innate host defense, and lung injurySusanne Herold, Stephan Ludwig, Stephan Pleschka, et al.
Cellular Microbiology|January 12, 2017
Influenza A virus NS1 protein-induced JNK activation and apoptosis are not functionally linkedWolfgang Nacken, Viktor Wixler, Christina Ehrhardt, et al.
Optics Letters|May 14, 2021
Single-pixel scatter-plate microscopyStephan Ludwig, Giancarlo Pedrini, Xiang Peng, et al.
Vaccine|May 12, 2012
Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccineDarisuren Anhlan, Eike-Roman Hrincius, Christoph Scholtissek, et al.
Scientific Reports|June 7, 2016
Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stabilitySabine Eva Dudek, Katja Nitzsche, Stephan Ludwig, et al.
Frontiers in Immunology|September 17, 2024
The anti-inflammatory and tolerogenic potential of small spleen peptidesViktor Wixler, Igor Z Zaytsev, Yvonne Boergeling, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2011
A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replicationAlexandra Nordmann, Ludmilla Wixler, Yvonne Boergeling, et al.
Frontiers in Microbiology|January 10, 2018
Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling PathwaysMagdalena Holzberg, Yvonne Boergeling, Tobias Schräder, et al.
Antiviral Research|June 19, 2007
CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in miceKaroline Droebner, Christina Ehrhardt, Anne Poetter, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Frontiers in Immunology|June 15, 2026
MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infectionFranziska Rodner, Klaus Schughart, Stephan Ludwig, et al.
Journal of Leukocyte Biology|February 21, 2012
Apoptosis signaling in influenza virus propagation, innate host defense, and lung injurySusanne Herold, Stephan Ludwig, Stephan Pleschka, et al.
Cellular Microbiology|January 12, 2017
Influenza A virus NS1 protein-induced JNK activation and apoptosis are not functionally linkedWolfgang Nacken, Viktor Wixler, Christina Ehrhardt, et al.
Optics Letters|May 14, 2021
Single-pixel scatter-plate microscopyStephan Ludwig, Giancarlo Pedrini, Xiang Peng, et al.
Vaccine|May 12, 2012
Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccineDarisuren Anhlan, Eike-Roman Hrincius, Christoph Scholtissek, et al.
Scientific Reports|June 7, 2016
Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stabilitySabine Eva Dudek, Katja Nitzsche, Stephan Ludwig, et al.
Frontiers in Immunology|September 17, 2024
The anti-inflammatory and tolerogenic potential of small spleen peptidesViktor Wixler, Igor Z Zaytsev, Yvonne Boergeling, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2011
A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replicationAlexandra Nordmann, Ludmilla Wixler, Yvonne Boergeling, et al.
Frontiers in Microbiology|January 10, 2018
Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling PathwaysMagdalena Holzberg, Yvonne Boergeling, Tobias Schräder, et al.
Antiviral Research|June 19, 2007
CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in miceKaroline Droebner, Christina Ehrhardt, Anne Poetter, et al.
Pageof 24